Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 10/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11543697 | 1.00 | ACHE (0.46) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL243893 | 1.00 | ACHE (0.46) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL6896832 | 1.00 | ACHE (0.46) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL27482175 | 1.00 | ACHE (0.46) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL6903485 | 1.00 | ACHE (0.46) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL6898154 | 1.00 | ACHE (0.46) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL357488 | 0.98 | ACHE (0.43) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| SCHEMBL1150883 | 0.92 | ACHE (0.36) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| Cyclopentanone SCHEMBL28849888 | 0.92 | ACHE (0.40) | ACHEBACE1PTGS2ALOX5PTPN1 | |
| Acetic Acid SCHEMBL9004840 | 0.90 | GAA (0.39) | ACHEBACE1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114853585-B | Heterogeneous catalysis double bond isomerization method | 江苏宏邦化工科技有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-114853585-A | Heterogeneous catalysis double bond isomerization method | 江苏宏邦化工科技有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-20080045596-A1 | Ep2 Receptor Agonists | ASTERAND, INC. | 2008-02-21 | — | — | US | disclosed |
| US-6833481-B2 | Catalytic dehydrative isomerization | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-12-21 | — | — | US | disclosed |
| US-20030109755-A1 | Process for producing 2-alkyl-2cyclopentenones | TAKASAGO INTERNATIONAL CORPORATION | 2003-06-12 | — | — | US | disclosed |
| EP-1316541-A1 | Process for producing 2-alkyl-2-cyclopentenones | Takasago International Corporation (JP) | 2003-06-04 | — | — | EP | disclosed |
| CN-1421429-A | Process for producing 2-alkyl-2-cyclopentenone | TAKASAGO PERFUMERY CO LTD (JP) | 2003-06-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109755-A1 | Process for producing 2-alkyl-2cyclopentenones | HSD3B2, DHPS, HSD3B1 | ACHE 4748/4885BACE1 4376/4885PTGS2 934/4885 |
| US-20080045596-A1 | Ep2 Receptor Agonists | PTGER2, PTGER1, PTGER3 | ACHE 1701/4885BACE1 2987/4885PTGS2 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.